EDGAR Filing Documents for 0001683168-22-001788

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001683168-22-001788

Filing Date

2022-03-21

Accepted

2022-03-21 07:46:38

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	sunshine_i10k-123121.htm iXBRL	10-K	816366
2	DESCRIPTION OF THE REGISTRANT'S SECURITIES	sunshine_ex0401.htm	EX-4.1	14573
3	CERTIFICATION	sunshine_ex3101.htm	EX-31.1	8239
4	CERTIFICATION	sunshine_ex3102.htm	EX-31.2	8236
5	CERTIFICATION	sunshine_ex3201.htm	EX-32.1	3670
6	GRAPHIC	image_007.jpg	GRAPHIC	11849
7	GRAPHIC	image_008.jpg	GRAPHIC	13466
8	GRAPHIC	image_009.jpg	GRAPHIC	18576
9	GRAPHIC	image_010.jpg	GRAPHIC	9687
	Complete submission text file	0001683168-22-001788.txt		3777330

Data Files

Seq	Description	Document	Type	Size
10	XBRL SCHEMA FILE	sbfm-20211231.xsd	EX-101.SCH	23340
11	XBRL CALCULATION FILE	sbfm-20211231_cal.xml	EX-101.CAL	41180
12	XBRL DEFINITION FILE	sbfm-20211231_def.xml	EX-101.DEF	103203
13	XBRL LABEL FILE	sbfm-20211231_lab.xml	EX-101.LAB	202773
14	XBRL PRESENTATION FILE	sbfm-20211231_pre.xml	EX-101.PRE	167698
45	EXTRACTED XBRL INSTANCE DOCUMENT	sunshine_i10k-123121_htm.xml	XML	362746

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)